Redsense Cares about Your Safety
Our vision is to save lives by detecting blood loss, using a patented core technology that utilizes fiber optics.
The Redsense blood loss detection solution is specifically designed to detect blood leakage through core technology utilizing fiber optics. Detected blood triggers a visual and audible alarm; thus giving patients, nurses and caregivers some extra peace of mind.
Redsense Medical AB (publ) håller årsstämma måndagen den 22 juni 2020 klockan 16.30 på Halmstad Lasarett, Sal: Ankaret, Ingång 19 A (gamla huvudentrén), Lasarettsvägen, Halmstad. Inregistrering sker från klockan 16.15. Före bolagsstämman visas bolagets produkter upp. RÄTT ATT DELTA OCH ANMÄLAN TILL BOLAGET Den som önskar delta i stämman ska dels vara införd […]
CEO Patrik Byhmer visited Biostock Studio and comments on Q1 2020 report in interview. “Redsense Medical has developed an alarm system that detects and warns of life-threatening blood leakage in connection with dialysis treatment. This is after a sales increase of 154 percent and the company’s first listed net profit as CEO Patrik Byhmer visits […]
FINANCIAL SUMMARY First quarter, 1 Januari – 31 Mars 2020 The Group Net sales amounted to kSEK 4,996 (1,964), a 154 percent increase compared with the corresponding period in 2019. Earnings before tax amounted to kSEK 241 (-706). Total equity amounted to kSEK 14,947 at the end of the period. Available liquid assets amounted to […]
Redsense Medical AB postpones the Annual General Meeting in an effort to contribute to social distancing and reduce the impact of the COVID-19 outbreak
The Board of Directors of Redsense Medical AB has resolved to postpone the Annual General Meeting of shareholders. The event will be held on Monday, 22 June 2020, 16:30, instead of 4 May 2020 as previously disclosed. Further information about the meeting will be announced at a later time. The publication dates for financial information are […]